Literature DB >> 28485800

GDF11 does not improve the palmitate induced insulin resistance in C2C12.

Y-Y Jing1, D Li, F Wu, L-L Gong, R Li.   

Abstract

OBJECTIVE: GDF11 (Growth Differentiation factor 11) has been reported to rejuvenate skeletal muscle, heart and brain in aged mice, and the aged skeletal muscle is closely related to insulin resistance. We wondered whether GDF11 has an effect on skeletal muscle insulin resistance.
MATERIALS AND METHODS: High fat diet induced obese mice with insulin resistance were established in vivo. Palmitate-induced insulin resistance in C2C12 myotubes was established in vitro. The mRNA expression of GDF11, GLUT4, IRS-1 (insulin receptor substrate-1) and PGC-1α (peroxisome proliferator-activated receptor-gamma coactivator 1) were tested by reverse transcriptase-polymerase chain reaction (RT-PCR). The protein level of GDF11 and PGC-1α were detected by Western blot. The glucose uptake was measured by 2NBDG uptake assay.
RESULTS: In high fat diet induced obese mice, both serum level of GDF11 and the expression of GDF11 in skeletal muscle decreased. Similarly, the expression of GDF11 also reduced in palmitate-treated C2C12 myotubes. In vitro, the glucose uptake and the expression of GLUT4, IRS-1 and PGC-1α significantly decreased after palmitate intervention, but GDF11 treatment did not reverse the reduction of glucose uptake and the expression of GLUT4, IRS-1 and PGC-1α in C2C12 myotubes.
CONCLUSIONS: We firstly confirmed that the expression of GDF11 decreased both in the skeletal muscle of obese mice and palmitate-treated myotubes, but supplementation GDF11 does not ameliorate the palmitate-induced insulin resistance in C2C12 myotubes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28485800

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy.

Authors:  Javier Duran; Mayarling Francisca Troncoso; Daniel Lagos; Sebastian Ramos; Gabriel Marin; Manuel Estrada
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

2.  Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes.

Authors:  Juan Añón-Hidalgo; Victoria Catalán; Amaia Rodríguez; Beatriz Ramírez; Camilo Silva; Juan C Galofré; Javier Salvador; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Aging (Albany NY)       Date:  2019-03-21       Impact factor: 5.682

3.  Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta/Smad signalling pathway.

Authors:  Hongke Luo; Yuchen Guo; Yuting Liu; Yuan Wang; Rixin Zheng; Yu Ban; Lin Peng; Quan Yuan; Weiqing Liu
Journal:  Cell Prolif       Date:  2019-04-30       Impact factor: 6.831

Review 4.  GDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies.

Authors:  Arturo Simoni-Nieves; Monserrat Gerardo-Ramírez; Gibrán Pedraza-Vázquez; Lisette Chávez-Rodríguez; Leticia Bucio; Verónica Souza; Roxana U Miranda-Labra; Luis E Gomez-Quiroz; María Concepción Gutiérrez-Ruiz
Journal:  Front Oncol       Date:  2019-10-15       Impact factor: 6.244

5.  GDF11 inhibits abnormal adipogenesis of condylar chondrocytes in temporomandibular joint osteoarthritis.

Authors:  Helin Wang; Yuqian Shi; Feng He; Tao Ye; Shibin Yu; Hui Miao; Qian Liu; Mian Zhang
Journal:  Bone Joint Res       Date:  2022-07       Impact factor: 4.410

Review 6.  Role of growth differentiation factor 11 in development, physiology and disease.

Authors:  Yonghui Zhang; Yong Wei; Dan Liu; Feng Liu; Xiaoshan Li; Lianhong Pan; Yi Pang; Dilong Chen
Journal:  Oncotarget       Date:  2017-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.